Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Tania Moujaber"'
Autor:
Lauren J Brown, Ines Pires da Silva, Tania Moujaber, Bo Gao, Rina Hui, Howard Gurney, Matteo Carlino, Adnan Nagrial
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 6788-6801 (2023)
Abstract Aims There is robust trial evidence for improved overall survival (OS) with immunotherapy in advanced solid organ malignancies. The real‐world long‐term survival data and the predictive variables are not yet known. Our aim was to evaluat
Externí odkaz:
https://doaj.org/article/6bb5dd3aed074dbb932c0084ce042e5f
Autor:
Golo Ahlenstiel, Adnan Nagrial, Dmitrii Shek, Joey Lai, Won-Hee Yoon, Tania Moujaber, Scott Read
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/20ac0dcdd7fc434f8eda0f6fddab8218
Autor:
Dmitrii Shek, Liia Akhuba, Matteo S. Carlino, Adnan Nagrial, Tania Moujaber, Scott A. Read, Bo Gao, Golo Ahlenstiel
Publikováno v:
Cancers, Vol 13, Iss 17, p 4345 (2021)
Background. Colorectal cancer (CRC) is the fourth most deadly cancer worldwide. Unfortunately, a quarter of the patients are diagnosed at late stages, when surgical options are limited. Targeted therapies, particularly immune-checkpoint inhibitors (I
Externí odkaz:
https://doaj.org/article/7b66c7adf9c8473f967a2971f7870fb4
Autor:
Lauren J Brown, Ines Pires da Silva, Tania Moujaber, Bo Gao, Rina Hui, Howard Gurney, Matteo Carlino, Adnan Nagrial
Publikováno v:
Cancer Medicine. 12:6788-6801
There is robust trial evidence for improved overall survival (OS) with immunotherapy in advanced solid organ malignancies. The real-world long-term survival data and the predictive variables are not yet known. Our aim was to evaluate factors associat
Autor:
Anna deFazio, David D.L. Bowtell, Ivan B. Lomakin, Helen Rizos, Martin Köbel, Sean M. Grimmond, Nicola Waddell, John V. Pearson, Timothy Semple, Timothy P. Holloway, Gisela Mir Arnau, George Au-Yeung, Joshy George, Ann-Marie Patch, Elizabeth L. Christie, Jason Li, Paul R. Harnett, Raghwa Sharma, Joy Hendley, Yoke-Eng Chiew, Chris Mitchell, Sian Fereday, Catherine J. Kennedy, Dale W. Garsed, Tania Moujaber, Ying Lei, Walid J. Azar, Dariush Etemadmoghadam
Low-grade serous ovarian carcinomas (LGSC) are associated with a poor response to chemotherapy and are molecularly characterized by RAS pathway activation. Using exome and whole genome sequencing, we identified recurrent mutations in the protein tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de61d8a9c700ed14b683350e2bb143e6
https://doi.org/10.1158/0008-5472.c.6509045.v1
https://doi.org/10.1158/0008-5472.c.6509045.v1
Autor:
Anna deFazio, David D.L. Bowtell, Ivan B. Lomakin, Helen Rizos, Martin Köbel, Sean M. Grimmond, Nicola Waddell, John V. Pearson, Timothy Semple, Timothy P. Holloway, Gisela Mir Arnau, George Au-Yeung, Joshy George, Ann-Marie Patch, Elizabeth L. Christie, Jason Li, Paul R. Harnett, Raghwa Sharma, Joy Hendley, Yoke-Eng Chiew, Chris Mitchell, Sian Fereday, Catherine J. Kennedy, Dale W. Garsed, Tania Moujaber, Ying Lei, Walid J. Azar, Dariush Etemadmoghadam
Supplemental Material - Group Authorship from EIF1AX and NRAS Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::027e670cd644246a5a5453c1a27413c2
https://doi.org/10.1158/0008-5472.22414655.v1
https://doi.org/10.1158/0008-5472.22414655.v1
Autor:
Anna deFazio, David D.L. Bowtell, Ivan B. Lomakin, Helen Rizos, Martin Köbel, Sean M. Grimmond, Nicola Waddell, John V. Pearson, Timothy Semple, Timothy P. Holloway, Gisela Mir Arnau, George Au-Yeung, Joshy George, Ann-Marie Patch, Elizabeth L. Christie, Jason Li, Paul R. Harnett, Raghwa Sharma, Joy Hendley, Yoke-Eng Chiew, Chris Mitchell, Sian Fereday, Catherine J. Kennedy, Dale W. Garsed, Tania Moujaber, Ying Lei, Walid J. Azar, Dariush Etemadmoghadam
Supplemental materials and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e83d93261f5411fcf3af9e9ea03cb1b
https://doi.org/10.1158/0008-5472.22414652.v1
https://doi.org/10.1158/0008-5472.22414652.v1
Autor:
Anna deFazio, David D.L. Bowtell, Ivan B. Lomakin, Helen Rizos, Martin Köbel, Sean M. Grimmond, Nicola Waddell, John V. Pearson, Timothy Semple, Timothy P. Holloway, Gisela Mir Arnau, George Au-Yeung, Joshy George, Ann-Marie Patch, Elizabeth L. Christie, Jason Li, Paul R. Harnett, Raghwa Sharma, Joy Hendley, Yoke-Eng Chiew, Chris Mitchell, Sian Fereday, Catherine J. Kennedy, Dale W. Garsed, Tania Moujaber, Ying Lei, Walid J. Azar, Dariush Etemadmoghadam
Supplementary Table S1. Patient characteristics; Supplementary Table S2. Ki67 proliferation index; Supplementary Table S3. WES and WGS performance statistics; Supplementary Table S4. Amplicon sequencing primers; Supplementary Table S5. High confidenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cba5e1bd54120fd9fe11574f4efad41
https://doi.org/10.1158/0008-5472.22414643
https://doi.org/10.1158/0008-5472.22414643
Autor:
Anna deFazio, David D.L. Bowtell, Ivan B. Lomakin, Helen Rizos, Martin Köbel, Sean M. Grimmond, Nicola Waddell, John V. Pearson, Timothy Semple, Timothy P. Holloway, Gisela Mir Arnau, George Au-Yeung, Joshy George, Ann-Marie Patch, Elizabeth L. Christie, Jason Li, Paul R. Harnett, Raghwa Sharma, Joy Hendley, Yoke-Eng Chiew, Chris Mitchell, Sian Fereday, Catherine J. Kennedy, Dale W. Garsed, Tania Moujaber, Ying Lei, Walid J. Azar, Dariush Etemadmoghadam
Supplementary Figure S1. Representative hematoxylin and eosin stained sections from sequenced LGSC; Supplementary Figure S2. Age distribution analysis of patients from the Australian Ovarian Cancer Study. Includes patients with advanced stage, serous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1960abba281de84b4bf2b4c7e3467af6
https://doi.org/10.1158/0008-5472.22414646.v1
https://doi.org/10.1158/0008-5472.22414646.v1
Publikováno v:
Endocrine-Related Cancer. 29:R1-R16
Low-grade serous ovarian cancer (LGSC) is a morphologically and molecularly distinct subtype of ovarian cancer, accounting for ~10% of serous carcinomas. Women typically present at a younger age and have a protracted clinical course compared with the